Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026)
Ovid Therapeutics (OVID) reported Other Working Capital Changes of -$110000.0 for Q1 2026, down 283.33% on a YoY basis from $60000.0 in Q1 2025, and up 93.5% quarter-over-quarter from -$1.7 million in Q4 2025.
Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Ovid Therapeutics has reported Other Working Capital Changes for 11 years, with the latest figure at -$110000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 283.33% year-over-year to -$110000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 10857.14% YoY), and the FY2025 full-year result was -$1.3 million, down 48.61% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$110000.0, up from -$1.7 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.7 million in Q3 2023, with the low at -$1.7 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$62899.5 across 5 years, with a median of -$110000.0 in 2026.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 2362.38% — and 2024, when it tumbled 395.16%.
- Ovid Therapeutics' Other Working Capital Changes stood at -$265513.0 in 2022, then tumbled by 230.3% to -$877000.0 in 2023, then slipped by 2.51% to -$899000.0 in 2024, then slumped by 88.21% to -$1.7 million in 2025, then soared by 93.5% to -$110000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$110000.0 (Q1 2026), -$1.7 million (Q4 2025), and -$522000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Dec 31, 2025 | -1.69 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Sep 30, 2025 | -522,000.00 |
| Sep 30, 2025 | -522,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Sep 30, 2024 | -151,000.00 |
| Sep 30, 2024 | -151,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | -853,000.00 |
| Mar 31, 2024 | -853,000.00 |
| Dec 31, 2023 | -877,000.00 |
| Dec 31, 2023 | -877,000.00 |